title: Cardiovascular Safety Warnings and the Prescribing of Varenicline: An Interrupted Time-series Analysis.
authors.affiliation: Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada, kristian.filion@mcgill.ca.
authors.forename: Kristian B
authors.initials: KB
authors.lastname: Filion
authors.forename: Maria
authors.initials: M
authors.lastname: Eberg
authors.forename: Laurent
authors.initials: L
authors.lastname: Azoulay
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002170:Canada; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D017277:Drug Approval; D004348:Drug Labeling; D004363:Drug Utilization / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000639:trends*; D061485:Tobacco Use Cessation Devices / Q000009:adverse effects*; D000068580:Varenicline / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D000068580:Varenicline